✦ LIBER ✦

Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab

✍ Scribed by Oshima, K; Sakata-Yanagimoto, M; Asano-Mori, Y; Izutsu, K; Watanabe, T; Shoda, E; Ogawa, S; Motokura, T; Chiba, S; Kurokawa, M

Book ID: 110014777
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 116 KB
Volume: 36
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705145

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of alemtuzumab after ha

Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignancies

✍ Kumi Oshima; Yoshinobu Kanda; Fumio Nakahara; Eriko Shoda; Takahiro Suzuki; Yoic 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

Late onset of autoimmune hemolytic anemi

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab

✍ Shinichi Kako; Yoshinobu Kanda; Kumi Oshima; Nahoko Nishimoto; Hiroyuki Sato; Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

Modified Donor Lymphocyte Infusion after

Modified Donor Lymphocyte Infusion after HLA-Mismatched/Haploidentical T Cell-replete Hematopoietic Stem Cell Transplantation for Prophylaxis of Relapse of Leukemia in Patients with Advanced Leukemia

✍ Xiao-Jun Huang; Dai-Hong Liu; Kai-Yan Liu; Lan-Ping Xu; Yu-Hong Chen; Yu Wang; W 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 155 KB

High CD4/CD8 ratio in allografts predict

High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia

✍ Lan-Ping Xu; Xiao-Hua Luo; Ying-Jun Chang; Dai-Hong Liu; Kai-Yan Liu; Yu-Hong Ch 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 180 KB

Case Report: Persistent cytomegalovirus

Case Report: Persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes

✍ Kumi Oshima; Yoshinobu Kanda; Shinichi Kako; Yuki Asano-Mori1; Takuro Watanabe; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract Addition of in vivo alemtuzumab to the conditioning regimen enabled 2‐ or 3‐locus‐mismatched hematopoietic stem cell transplantation with an acceptable incidence of graft‐versus‐host‐disease. However, the procedure was associated with a high incidence of cytomegalovirus (CMV) reactivati

Successful non-T-cell-depleted nonmyeloa

Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism

✍ Tsutsumi, Y; Tanaka, J; Miura, T; Saitoh, S; Yamada, M; Yamato, H; Ehira, N; Kan 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB